With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Influenza activity remains elevated in South America, has started to decline in southern Africa, and is still below seasonal threshold levels in Australia and New Zealand, the World Health Organization (WHO) said in its latest update.
After several months of silence, the Saudi Arabian Ministry of Health (MOH) recently uploaded information on 30 new MERS-CoV case detections on its website, including a cluster of 11 household cases from Najran detected in late May and early June.
Data from 3 flu seasons show obese adults shed the virus about 1.5 times longer than non-obese adults.
The Southern Hemisphere's flu season, which typically lasts through October, shows mixed patterns, with activity that may have peaked in southern Africa, is increasing in South America, and is still below seasonal thresholds in Australia and New Zealand, the World Health Organization (WHO) said in its latest global flu update.
The California Department of Public Health (CDPH) yesterday announced that a baby from San Bernardino County has died from pertussis, marking the state's first death from the disease since 2016.
A phase 3 study of the novel antiviral baloxavir marboxil suggests that it reduces symptoms in people at high risk of flu complications, Roche announced today.
BARDA will provide $24 million in initial funds to 2 companies to advance tests for influenza A and B.
A new report from the World Health Organization's (WHO's) Eastern Mediterranean regional office shows four more MERS- CoV cases reported by Saudi Arabia in June, one of them fatal.
The WHO said none of the four cases of appears to be in a cluster. In late May, Saudi officials identified clusters of cases in Najran and Jeddah linked to household outbreaks.
The US Food and Drug Administration (FDA) has granted fast-track approval for a new oral antiviral with a different mechanism of action than neuraminidase inhibitors that offers one-dose treatment, according to a Jun 25 statement from Genentech, part of the Roche Group. The drug, called baloxavir marboxil, was approved in Japan in February for the treatment of influenza A and B in adult and pediatric patients.
In a World Health Organization (WHO) African regional office weekly bulletin, Kenya reported an additional 44 cases of Rift Valley fever (RVF), including 6 deaths, in an ongoing outbreak of the virus.
The spike in cases raises outbreak totals to 54 cases, including 11 deaths, resulting in a case-fatality rate of 20.4%. Men ages 21 to 30 years old make up 70% of the patients.
